Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The history now includes a new version entry (v3.3.4) and removes v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:48:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a new Revision: v3.3.3 entry; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T07:58:00.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors was replaced with a broader 'Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers (SYNERGY-101)'. The update adds or updates sections including Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Oversight, Study Status, and Study Identification.
    Difference
    1%
    Check dated 2025-12-01T15:11:16.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision v3.3.1 was added to the study record history, and the v3.2.0 revision was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:38:36.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The government funding lapse notice regarding operating status and updates has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T06:22:27.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The new screenshot shows the same page with minor visual adjustments to header spacing and table presentation, and no substantive changes to study data or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:58:39.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.